Isotretinoin
Prescription ·Exploratory record · not publication-reviewed ·Updated July 13, 2026
Isotretinoin (13-cis-retinoic acid) is the most effective treatment for severe, recalcitrant nodular acne that has failed conventional therapy. It is the only acne medication that addresses all four pathogenic factors of acne: excess sebum production, follicular hyperkeratinization, Cutibacterium acnes colonization, and inflammation. A typical course of 15-20 weeks achieves long-term remission in most patients, with many cured after a single course.
Exploratory record, not a reviewed medical publication.
See the editorial and medical-review policies for the publication gate.
This generated database record has not completed a claim-level review by a qualified human medical reviewer. Bibliography links and evidence labels are not approval. The page remains available for reference and is excluded from search indexing.
What the research says.
A quick, data-only summary. The full evidence, dosing, and sources are below.
Isotretinoin (13-cis-retinoic acid) is the most effective treatment for severe, recalcitrant nodular acne that has failed conventional therapy. NutriStack rates the supporting evidence as strong. Common adult dosing is 0.5-1 mg/kg/day in 1-2 divided doses for 15-20 weeks; cumulative dose target of 120-150 mg/kg (as prescribed by your physician), though a prescriber sets the actual dose. This profile indexes 10 sources.
- Dry skin, lips, and mucous membranes (cheilitis in ~90% of patients)
- Dry eyes and contact lens intolerance
- Elevated triglycerides and cholesterol
- Pregnancy (absolutely contraindicated, severe teratogen causing birth defects)
- Breastfeeding
The bottom line
Evidence rating strong. Most-documented uses: long-term remission of severe acne (often permanent after one course), addresses all four pathogenic factors of acne simultaneously, dramatically reduces sebum production. 10 sources indexed (2022–2025), with 0 interaction records on file.
How it works, mechanistically.
Core mechanism
Acts as a retinoid (vitamin A derivative) that dramatically reduces sebaceous gland size and sebum production by up to 90%, normalizes follicular keratinization to prevent comedone formation, inhibits Cutibacterium acnes growth (indirectly through reduced sebum), and exerts anti-inflammatory effects. These combined actions address all major pathogenic factors of acne. The precise molecular targets include retinoid receptors (RAR/RXR), regulation of gene transcription, and modulation of toll-like receptor signaling.
Dosing & protocol.
Take with high-fat meal, absorption increases 2x with food. Absorica (micronized formulation) can be taken without food with comparable bioavailability. Peak levels in 3-5 hours.1,9
Full safety detail.
Side effects
- Dry skin, lips, and mucous membranes (cheilitis in ~90% of patients)
- Dry eyes and contact lens intolerance
- Elevated triglycerides and cholesterol
- Elevated liver enzymes
- Musculoskeletal pain and myalgias
- Photosensitivity
- Mood changes and depression (debated; monitoring recommended)
- Nosebleeds (epistaxis)
Contraindications
- Pregnancy (absolutely contraindicated, severe teratogen causing birth defects)
- Breastfeeding
- Hypersensitivity to isotretinoin, retinoids, or parabens in capsule1,2
- Concurrent vitamin A supplementation (hypervitaminosis A risk)
- Concurrent tetracycline antibiotics (pseudotumor cerebri risk)
- Hypertriglyceridemia
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Meta-analyses & systematic reviews
5- 1Low-dose isotretinoin for the management of rosacea: A systematic review and meta-analysisPMIDKing A, Tan MG, Kirshen C et al. · Journal of the European Academy of Dermatology and Venereology : JEADV · 2025
King A, Tan MG, Kirshen C et al.. Low-dose isotretinoin for the management of rosacea: A systematic review and meta-analysis. Journal of the European Academy of Dermatology and Venereology : JEADV. 2025
- 2The Impact of Isotretinoin on Lipid Profile: a Systematic ReviewPMIDSibi Krishna T, Kaur R, Malhotra V et al. · Annals of medicine and surgery (2012) · 2025
Sibi Krishna T, Kaur R, Malhotra V et al.. The Impact of Isotretinoin on Lipid Profile: a Systematic Review. Annals of medicine and surgery (2012). 2025
- 3Side Effects of Treating Acne Vulgaris With Isotretinoin: A Systematic ReviewPMIDRajput I, Anjankar VP · Cureus · 2024
Rajput I, Anjankar VP. Side Effects of Treating Acne Vulgaris With Isotretinoin: A Systematic Review. Cureus. 2024
- 4Combinations of Energy-based Devices plus isotretinoin for management of acne and acne scars: A systematic reviewPMIDXu Y, Wang H, Guo L et al. · Journal of cosmetic dermatology · 2024
Xu Y, Wang H, Guo L et al.. Combinations of Energy-based Devices plus isotretinoin for management of acne and acne scars: A systematic review. Journal of cosmetic dermatology. 2024
- 5Adverse Events in Isotretinoin Therapy: A Single-Arm Meta-AnalysisPMIDKapała J, Lewandowska J, Placek W et al. · International journal of environmental research and public health · 2022
Kapała J, Lewandowska J, Placek W et al.. Adverse Events in Isotretinoin Therapy: A Single-Arm Meta-Analysis. International journal of environmental research and public health. 2022
Reference material
5- 6Layton AM et al. A review on the treatment of acne vulgaris, an evidence-based update. J Eur Acad Dermatol Venereol. 2009;23(4):439-448.Source linkedPMID
- 7Strauss JS et al. Guidelines of care for acne vulgaris management. J Am Acad Dermatol. 2007;56(4):651-663.Source linkedPMID
- 8Dispenza MC et al. Systemic isotretinoin therapy normalizes exaggerated TLR-2-mediated innate immune responses in acne patients. J Invest Dermatol. 2012;132(9):2198-2205.Source linkedPMID
- 9Sadeghzadeh-Bazargan A, Ghassemi M, Goodarzi A et al.. Systematic review of low-dose isotretinoin for treatment of acne vulgaris: Focus on indication, dosage, regimen, efficacy, safety, satisfaction, and follow up, based on clinical studies. Dermatologic therapy. 2021Source linkedPMID
- 10Vallerand IA, Lewinson RT, Farris MS et al.. Efficacy and adverse events of oral isotretinoin for acne: a systematic review. The British journal of dermatology. 2018Source linkedPMID
Common questions.
Quick answers about Isotretinoin, drawn from the data on this page.
What is Isotretinoin?
Isotretinoin (13-cis-retinoic acid) is the most effective treatment for severe, recalcitrant nodular acne that has failed conventional therapy. It is the only acne medication that addresses all four pathogenic factors of acne: excess sebum production, follicular hyperkeratinization, Cutibacterium acnes colonization, and inflammation. A typical course of 15-20 weeks achieves long-term remission in most patients, with many cured after a single course.
What is Isotretinoin used for?
Commonly cited benefits of Isotretinoin include: Long-term remission of severe acne (often permanent after one course); Addresses all four pathogenic factors of acne simultaneously; Dramatically reduces sebum production; Most effective acne medication available. NutriStack rates the overall evidence as strong.
What is a typical dose of Isotretinoin?
A typical adult dose of Isotretinoin is 0.5-1 mg/kg/day in 1-2 divided doses for 15-20 weeks; cumulative dose target of 120-150 mg/kg (as prescribed by your physician). The commonly recommended form is Oral capsules; Absorica can be taken without food, other brands require fat-containing meal. These are general ranges, not personalized advice; confirm the right dose with a clinician.
What are the side effects of Isotretinoin?
Reported side effects include dry skin, lips, and mucous membranes (cheilitis in ~90% of patients), dry eyes and contact lens intolerance, elevated triglycerides and cholesterol, elevated liver enzymes, musculoskeletal pain and myalgias, photosensitivity. This is educational information; check with a healthcare professional before use.
How strong is the evidence for Isotretinoin?
NutriStack rates this as Strong, meaning multiple high-quality meta-analyses or systematic reviews converge on the same finding. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
Use this with your stack
Isotretinoin in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.